However, an association of CCL5 rs2107538 (−403C > T) with protection against the development of CCC was observed for CT heterozygotes and T carriers, when cardiopathic with CHF patients (C group) were compared with non-cardiopathic (A group) patients. This evidence concerns the gene CCL5 and congestive heart failure.